跳至主要内容
临床试验/DRKS00014556
DRKS00014556招募中不适用

Assessment of metal concentrations in cerebrospinal fluid, whole blood and serum of patients with arthroplasty implants in situ who undergo lumbar puncture in the course of the diagnostic workup or therapy of neurological disease(s) – a pilot study - NeuroWear II

Centrum für Muskuloskeletale Chirurgie, Charité - Universitätsmedizin Berlin0 个研究点目标入组 40 人开始时间: 2018年4月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • age = 18 years
  • - written informed consent
  • - scheduled for lumbar puncture in the course of clinical routine (i.e. to rule out or treat neurological diseases / disorders)
  • - at least one major endoprosthesis (i.e. artificial hip, knee, ankle, shoulder or elbow joint) in situ or respective age- (± 5 years) and sex-matched controls without arthroplasty implant in situ

排除标准

  • - age < 18 years
  • - patients under legal guardianship for medical decision making

研究者

发起方
Centrum für Muskuloskeletale Chirurgie, Charité - Universitätsmedizin Berlin

相似试验

Assessment of metal concentrations in cerebrospinal... | 临床试验